Brought to you by Diabetes & Primary Care, the three mini-case studies presented below take you through what it is necessary to consider in identifying and managing steroid-induced hyperglycaemia. Each scenario provides a different set of circumstances that you could meet in your everyday practice. By actively engaging with them, you will feel more confident and empowered to manage effectively such problems in the future.
- American Diabetes Association (2020) 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes. Diabetes Care 43(Suppl 1): S14–S31
- WHO, IDF (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF consultation. Available at: https://bit.ly/2PtZbTu (accessed 05.03.21)
- Evans P, Sidaway-Lee K (2015) Clinical presentations and diagnosis of diabetes. Diabetes & Primary Care 17: 36–43 (https://bit.ly/38dSwDw)
- NHS England (2021) Healthier Your: NHS Diabetes Prevention Programme. Available at: https://bit.ly/3r94HIx (accessed 23.03.21)
- John WG, Hillson R, Alberti SG (2012) Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organisation (WHO) guidance 2011. Practical Diabetes 29: 12–12a
- WHO (2011) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. Available at: https://bit.ly/2PyeSsR (accessed 05.03.21)
- NICE (2015) Type 2 diabetes in adults: management (NG28). Available at: https://www.nice.org.uk/guidance/ng28 (accessed 05.03.21)
- Chatterton A, Younger T, Fischer A, Khunti K (2012) Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. BMJ 345: 42–4
- Continho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. Diabetes Care 22: 233–40
- UKPDS Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–53
- Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362: 800–11
- de Lusignan S, Sadek N, Mulnier H et al (2012) Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med 29: 181–9
- NICE (2012) Type 2 diabetes: prevention in people at high risk (PH38). Available at: https://www.nice.org.uk/guidance/ph38 (accessed 05.03.21)
- Diabetes UK (2021) Type 2 Diabetes: Know Your Risk. Available at: https://riskscore.diabetes.org.uk/start (accessed 23.03.21)
Questions Summary
0 of 17 Questions completed
Questions:
Information
You have already completed the questions before. Hence you can not start it again.
Questions is loading…
You must sign in or sign up to start the questions.
You must first complete the following:
Results
Results
Your time:
Time has elapsed
Categories
- Not categorized 0%
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 17
1. Question
-
Question 2 of 17
2. Question
-
Question 3 of 17
3. Question
-
Question 4 of 17
4. Question
-
Question 5 of 17
5. Question
-
Question 6 of 17
6. Question
-
Question 7 of 17
7. Question
-
Question 8 of 17
8. Question
-
Question 9 of 17
9. Question
-
Question 10 of 17
10. Question
-
Question 11 of 17
11. Question
-
Question 12 of 17
12. Question
-
Question 13 of 17
13. Question
-
Question 14 of 17
14. Question
-
Question 15 of 17
15. Question
This response will be awarded full points automatically, but it can be reviewed and adjusted after submission.